Primary sclerosing cholangitis – a comprehensive review

Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. Inflammatory bowel disease is usually present and there is a high risk of cholangiocarcinoma and colorectal cancer. Most patients ultimately require liver transpla...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of hepatology Ročník 67; číslo 6; s. 1298 - 1323
Hlavní autoři: Karlsen, Tom H., Folseraas, Trine, Thorburn, Douglas, Vesterhus, Mette
Médium: Journal Article
Jazyk:angličtina
Vydáno: Netherlands Elsevier B.V 01.12.2017
Elsevier Science Ltd
Témata:
Bile ducts
Biopsy
Cholangiocarcinoma
Cholangitis
Cholangitis, Sclerosing - diagnosis
Cholangitis, Sclerosing - etiology
Cholangitis, Sclerosing - genetics
Cholangitis, Sclerosing - therapy
Colorectal cancer
Colorectal carcinoma
Genetic Predisposition to Disease
Humans
IgG4-associated cholangitis
Inflammatory bowel diseases
Inflammatory diseases
Intestine
Liver - pathology
Liver diseases
Liver Transplantation
Pathogenesis
Primary sclerosing cholangitis
Quality of Life
Risk factors
Stricture
Transplants & implants
Primary sclerosing cholangitis
Cholangiocarcinoma
IgG4-associated cholangitis
ISSN:0168-8278, 1600-0641, 1600-0641
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. Inflammatory bowel disease is usually present and there is a high risk of cholangiocarcinoma and colorectal cancer. Most patients ultimately require liver transplantation, after which disease recurrence may occur. With limited therapeutic options and a lack of proven surveillance strategies, patients currently have significant unmet needs. In the present seminar, we provide a comprehensive review of the status of the field. We emphasise developments related to patient stratification and disease behaviour, and provide an overview of management options from a practical, patient-centered perspective. We survey advances made in the understanding of PSC pathogenesis and summarise the ongoing efforts to develop an effective therapy based on these insights.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0168-8278
1600-0641
1600-0641
DOI:10.1016/j.jhep.2017.07.022